Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

45 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Metronomics chemotherapy: time for computational decision support.
Barbolosi D, Ciccolini J, Meille C, Elharrar X, Faivre C, Lacarelle B, André N, Barlesi F. Barbolosi D, et al. Cancer Chemother Pharmacol. 2014 Sep;74(3):647-52. doi: 10.1007/s00280-014-2546-1. Epub 2014 Aug 1. Cancer Chemother Pharmacol. 2014. PMID: 25082520 Review.
Revisiting Bevacizumab + Cytotoxics Scheduling Using Mathematical Modeling: Proof of Concept Study in Experimental Non-Small Cell Lung Carcinoma.
Imbs DC, El Cheikh R, Boyer A, Ciccolini J, Mascaux C, Lacarelle B, Barlesi F, Barbolosi D, Benzekry S. Imbs DC, et al. Among authors: barbolosi d. CPT Pharmacometrics Syst Pharmacol. 2018 Jan;7(1):42-50. doi: 10.1002/psp4.12265. Epub 2017 Dec 7. CPT Pharmacometrics Syst Pharmacol. 2018. PMID: 29218795 Free PMC article.
Ang1 and Tie2 are predictive biomarkers for bevacizumab-letter.
Ciccolini J, Serdjebi C, Barbolosi D, Lacarelle B, Barlesi F. Ciccolini J, et al. Among authors: barbolosi d. Clin Cancer Res. 2015 Feb 15;21(4):934. doi: 10.1158/1078-0432.CCR-14-2832. Clin Cancer Res. 2015. PMID: 25691775 No abstract available.
A phase Ia/Ib clinical trial of metronomic chemotherapy based on a mathematical model of oral vinorelbine in metastatic non-small cell lung cancer and malignant pleural mesothelioma: rationale and study protocol.
Elharrar X, Barbolosi D, Ciccolini J, Meille C, Faivre C, Lacarelle B, André N, Barlesi F. Elharrar X, et al. Among authors: barbolosi d. BMC Cancer. 2016 Apr 20;16:278. doi: 10.1186/s12885-016-2308-z. BMC Cancer. 2016. PMID: 27094927 Free PMC article. Clinical Trial.
45 results